Blar i NTNU Open på forfatter "Mecinaj, Albulena"

Viser treff 1-4 av 4

    • Cardiac Dysfunction and Arrhythmias 3 Months After Hospitalization for COVID-19 

      Ingul, Charlotte Ingeborg Björk; Grimsmo, Jostein; Mecinaj, Albulena; Trebinjac, Divna; Nossen, Magnus Berger; Andrup, Simon; Grenne, Bjørnar; Dalen, Håvard; Einvik, Gunnar; Stavem, Knut; Follestad, Turid; Josefsen, Tony Andre; Omland, Torbjørn; Jensen, Torstein (Peer reviewed; Journal article, 2022)
      Background - The extent of cardiac dysfunction post‐COVID‐19 varies, and there is a lack of data on arrhythmic burden. Methods and Results - This was a combined multicenter prospective cohort study and cross‐sectional ...

    • Cardiac pathology 6 months after hospitalization for COVID-19 and association with the acute disease severity 

      Myhre, Peder Langeland; Heck, Siri Lagethon; Skranes, Julia Brox; Prebensen, Christian Haugland; Jonassen, Christine M; Berge, Trygve; Mecinaj, Albulena; Einvik, Gunnar; Melles, Woldegabriel A; Ingul, Charlotte Bjørk; Tveit, Arnljot; Berdal, Jan-Erik; Røsjø, Helge Rørvik; Lyngbakken, Magnus Nakrem; Omland, Torbjørn (Peer reviewed; Journal article, 2021)
      Background Coronavirus disease 2019 (COVID-19) may cause myocardial injury and myocarditis, and reports of persistent cardiac pathology after COVID-19 have raised concerns of long-term cardiac consequences. We aimed to ...

    • Changes in cardiac structure and function from 3 to 12 months after hospitalization for COVID-19 

      Øvrebotten, Tarjei; Myhre, Peder Langeland; Grimsmo, Jostein; Mecinaj, Albulena; Trebinjac, Divna; Nossen, Magnus Berger; Andrup, Simon Johan Mattias; Josefsen, Tony Andre; Einvik, Gunnar; Stavem, Knut; Omland, Torbjørn; Ingul, Charlotte Ingeborg Björk (Journal article; Peer reviewed, 2022)

    • Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trial 

      Mecinaj, Albulena; Gulati, Geeta; Heck, Siri Lagethon; Holte, Espen; Fagerland, Morten Wang; Larsen, Alf Inge; Blix, Egil Støre; Geisler, Jürgen; Wethal, Torgeir; Omland, Torbjørn (Journal article, 2021)
      Background Recent advances in the treatment algorithms of early breast cancer have markedly improved overall survival. However, anthracycline- and trastuzumab-associated cardiotoxicity may lead to dose-reduction or halt ...